|midatech pharma plc news||1.49||0.9||6511||41|
Midatech Pharma plc (NASDAQ: MTP) has raised £10 million from equity placing to fund its product development pipeline. Approximately 35 million new shares in the Company were issued at 28.5p each, a 12% discount on Monday's closing price.What does Midatech do?
Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.How do I contact Midatech Pharma?
The company can be reached via phone at 441235888300 or via email at [email protected] View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Who owns mitmidatech pharma's stock?
Midatech Pharma's stock is owned by a number of institutional and retail investors. Top institutional investors include Lombard Odier Asset Management USA Corp (2.33%), Renaissance Technologies LLC (1.73%) and Morgan Stanley (1.27%).